Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 119
Selected: 0
NCT IDTitle
NCT04139772Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
NCT06905145Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT07314853Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT02633189Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer
NCT03473379Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy
NCT05233982MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
NCT02381054Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT00412022HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
NCT00401609G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
NCT01651026Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT06714357ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT05806151Prediction of True Oligo-metastatic Disease.
NCT07302451REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
NCT07213557Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy
NCT02784171Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
NCT04122911Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
NCT04317092Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT01405586MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
NCT01359956Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT07027046Application of da Vinci SP for Endometrial Cancer Surgical Staging
NCT01755182Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
NCT02408536Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
NCT04726228Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
NCT06236464Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT00330746CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT03410784Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT01405573Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
NCT04129255Octreotide LAR in the Induction of Immunologic Response in NENs Patients
NCT02069067Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT06884878Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
NCT01061619Pathway to Diagnosis of Ovarian Cancer
NCT00434031CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
NCT00540800BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
NCT03874026Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
NCT04416672Validation of the Italian Version of the PRO-CTCAE
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT00996983Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer
NCT01718873Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer